pharmaphorum

JANUARY 5, 2023

Nonetheless, Moderna has previously been involved in licensing deals to advance its technology. The data was from their phase 2b trial of a personalised vaccine consisting of 34 mRNAs, each targeting mutations – identified by gene sequencing – thought to be driving a patient’s cancer.

Gene Sequencing 97

Gene Sequencing DNA Vaccination Vaccine 97

pharmaphorum

MAY 18, 2021

It has already filed a rolling license application in Canada, and has also picked up fast-track status for the shot from the US FDA. If the data are positive, the company could be looking at emergency approvals in the latter half of the year.

Immune Response 65

Immune Response Vaccination Vaccine Gene Sequencing 65

pharmaphorum

OCTOBER 1, 2021

It may also use the cash injection for “in-licensing opportunities and potential acquisitions”, according to the document. The post Oxford Nanopore makes stellar debut on UK stock market appeared first on.

Marketing 52

Marketing Business Development Genome Genomics 52

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. As per the company, dbDNA is suitable for rapid, scalable manufacture of GMP DNA and can incorporate gene sequences of sizes ranging from 500bp to 20kb, which are typically unstable as pDNA.

DNA 130

DNA Manufacturing Gene Therapy Gene 130

pharmaphorum

FEBRUARY 19, 2021

In November 2019 it was licensed for use by the European Medicines Agency and is now prequalified by WHO, the US FDA, as well as in eight African countries. This is a priority area for us to ensure that all African countries are equipped to carry out gene sequencing locally or can send samples to reference laboratories.”.

Vaccination 65

Vaccination Vaccine Gene Sequencing Manufacturing 65